Laura Bessen
CIK: 0001926815
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CCCC
C4 Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Bessen Laura
Bessen Laura (SEC CIK 0001926815) files insider reports with the SEC as Director of C4 Therapeutics, Inc. (CCCC).
Signal8 holds 2 ownership filings by Bessen Laura, all Form 4s, filed between Jun 20, 2025 and Jun 26, 2026. Those filings report 2 transactions, from Jun 18, 2025 to Jun 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bessen Laura's filings is in WATERTOWN, MA.
Recent filings by Bessen Laura
Other insiders filing for C4 Therapeutics, Inc. (CCCC)
- Anderson Kenneth Carl, Director
- GROGAN DONNA ROY, Director
- Adams Kendra, Chief Financial Officer
- REYNO LEONARD, Chief Medical Officer
- Hughes Owen, Director
- Hoerter Steven L., Director